US Stock MarketDetailed Quotes

CYTO Altamira Therapeutics

Watchlist
  • 0.6100
  • -0.0100-1.61%
Trading Oct 15 09:35 ET
2.30MMarket Cap0.04P/E (TTM)

Altamira Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Altamira Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CHF

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 0.000--
--2024/H2-- / 0.000--
Sep 24, 20242024/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 0.000--
--2024/H2-- / 0.000--
Sep 24, 20242024/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Altamira Therapeutics Earnings Reports

  • Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 24 08:16 ET

  • Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 19 16:21 ET

  • Altamira Therapeutics | 20-F/A: FY2023 Annual Report

    Jul 1 07:13 ET

  • Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Apr 22 22:18 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data